文献速递糖尿病

糖尿病与特发性肺纤维化关联:2600万人研究级汇总分析

Associations Between Diabetes and Idiopathic Pulmonary Fibrosis: a Study-level Pooled Analysis of 26 Million People.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

IPF患者中糖尿病的合并OR为1.54(95%CI 1.30-1.84;95%CI 0.64-1.25;

要点

  • IPF患者中糖尿病患病 odds 较非IPF对照升高1.54倍(95%CI 1.30-1.84)。
  • 糖尿病与IPF的关联方向尚需大型前瞻性队列研究进一步验证。

核心结论

  • 糖尿病患者是否增加IPF风险仍存争议,需进一步大型前瞻性队列研究。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、EMBASE和Cochrane Library。
  • 两名研究者独立筛选文献并提取数据,合并OR及95%CI为效应指标。

临床怎么用

  • 内分泌科医生在管理糖尿病患者时,应关注IPF相关呼吸道症状,但当前证据不支持糖尿病作为IPF的明确危险因素。

局限性

  • 纳入研究以IPF人群为主(16项),仅2项研究从糖尿病人群出发评估IPF患病率。
  • 研究间异质性及混杂因素控制情况未在摘要中报告。
  • 原文指出需进一步大型前瞻性队列研究验证糖尿病患者中IPF的患病情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Diabetes mellitus (DM) is a systemic disease characterized by chronic hyperglycemia associated with inflammation and oxidative stress, and the lung may be a target organ of diabetic microvascular damage. Several studies have indicated a positive association between idiopathic pulmonary fibrosis (IPF) and diabetes with controversial findings. OBJECTIVE: Primary outcomes were to compare the prevalence of DM among individuals with IPF to non-IPF controls, and the prevalence of IPF among individuals with DM to non-DM controls. METHODS: Data sources include PubMed, EMBASE, and the Cochrane Library. Studies contained sufficient data to calculate the prevalence of DM among individuals with and without IPF, or the prevalence of IPF among individuals with and without DM. Two investigators independently identified eligible studies and extracted data. Pooled odds ratio (OR) with 95% CI was the summary effect measure. RESULTS: Eighteen studies including 26 410 623 individuals met the eligibility criteria, of whom 16 recruited people with IPF and 2 recruited people with DM. The OR of DM in IPF patients was 1.54 (95% CI, 1.30-1.84; P < .001) compared to that in non-IPF controls. However, compared with that in non-DM patients, the risk of IPF in DM patients was not found to be significantly reduced (OR: 0.89; 95% CI, 0.64-1.25; P = .497). CONCLUSION: This meta-analysis suggests that people with IPF have 1.54 times increased odds of diabetes compared to non-IPF controls, while whether patients with DM have an increased risk of IPF is still controversial. Further large, prospective cohort studies investigating the prevalence of IPF in diabetic patients are warranted.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li C, Xiao Y, Hu J, et al. Associations Between Diabetes and Idiopathic Pulmonary Fibrosis: a Study-level Pooled Analysis of 26 Million People. J Clin Endocrinol Metab. 2021. PMID: 34302736. doi:10.1210/clinem/dgab553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。